Capricor Therapeutics, Inc.
CAPR
$6.97
$0.081.16%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.12M | -12.56M | -11.00M | -9.79M | -762.10K |
| Total Depreciation and Amortization | 375.70K | 361.20K | 356.90K | 331.40K | 307.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.39M | 2.04M | 2.14M | 3.26M | 1.85M |
| Change in Net Operating Assets | -10.45M | -1.49M | -3.79M | 4.94M | -12.99M |
| Cash from Operations | -14.80M | -11.64M | -12.29M | -1.27M | -11.59M |
| Capital Expenditure | -734.70K | -59.00K | -80.90K | -664.30K | -729.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -122.65M | 2.06M | 14.78M | -8.84M | -5.13M |
| Cash from Investing | -123.38M | 2.00M | 14.70M | -9.50M | -5.86M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 81.09M | 67.33M | 2.07M | 2.29M | 23.17M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 81.09M | 67.33M | 2.07M | 2.29M | 23.17M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -57.09M | 57.69M | 4.47M | -8.48M | 5.71M |